Ge Li-Ping, Liu Xi-Yu, Xiao Yi, Gou Zong-Chao, Zhao Shen, Jiang Yi-Zhou, Di Gen-Hong
Department of Breast Surgery, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China,
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China,
Cancer Manag Res. 2018 Oct 9;10:4381-4391. doi: 10.2147/CMAR.S169019. eCollection 2018.
Occult breast cancer (OBC) is a rare type of breast cancer that has not been well studied. The clinicopathological characteristics and treatment recommendations for OBC are based on a limited number of retrospective studies and thus remain controversial.
We identified 479 OBC patients and 115,739 non-OBC patients from 2004 to 2014 in and the Surveillance, Epidemiology, and End Results (SEER) database. The clinicopathological characteristics and survival outcomes were compared between OBC and non-OBC patients. We used the propensity score 1:1 matching analysis to evaluate OBC vs non-OBC comparison using balanced groups with respect to the observed covariates. We further divided the OBC population into four groups based on different treatment strategies. Univariable and multivariable analyses were used to calculate and compare the four treatment outcomes within the OBC population.
OBC patients were older, exhibited a more advanced stage, a higher rate of negative estrogen receptor and progesterone receptor status, a higher rate of HER2-positive status, and a higher rate of ≥10 positive lymph nodes, and were less likely to undergo surgical treatment than non-OBC patients. After adjustments for clinicopathological factors, the OBC patients exhibited a significantly better survival than the non-OBC patients (<0.001). This result was confirmed in a 1:1 matched case-control analysis. Within the four OBC treatment groups, we observed no difference in survival among the mastectomy group, the breast-conserving surgery (BCS) group, and the axillary lymph node dissection (ALND)-only group. The multivariable analysis revealed that the sentinel lymph node dissection-only group had the worst prognosis (<0.001). OBC has unique clinicopathological characteristics and a favorable prognosis compared with non-OBC. BCS plus ALND and radiotherapy showed a survival benefit that was similar to that of mastectomy for OBC patients.
隐匿性乳腺癌(OBC)是一种罕见的乳腺癌类型,尚未得到充分研究。OBC的临床病理特征和治疗建议基于数量有限的回顾性研究,因此仍存在争议。
我们从监测、流行病学和最终结果(SEER)数据库中识别出2004年至2014年期间的479例OBC患者和115739例非OBC患者。比较了OBC患者和非OBC患者的临床病理特征及生存结局。我们使用倾向评分1:1匹配分析,以观察到的协变量为基础,在平衡组中评估OBC与非OBC的比较。我们根据不同的治疗策略将OBC人群进一步分为四组。采用单变量和多变量分析来计算和比较OBC人群中的四种治疗结果。
与非OBC患者相比,OBC患者年龄更大,分期更晚,雌激素受体和孕激素受体阴性率更高,HER2阳性率更高,≥10个阳性淋巴结的比例更高,且接受手术治疗的可能性更小。在对临床病理因素进行调整后,OBC患者的生存率明显高于非OBC患者(<0.001)。这一结果在1:1匹配的病例对照分析中得到了证实。在四个OBC治疗组中,我们观察到乳房切除术组、保乳手术(BCS)组和仅腋窝淋巴结清扫(ALND)组之间的生存率没有差异。多变量分析显示,仅前哨淋巴结清扫组的预后最差(<0.001)。与非OBC相比,OBC具有独特的临床病理特征和良好的预后。对于OBC患者,BCS加ALND和放疗显示出与乳房切除术相似的生存获益。